//
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y
Heart Failure With Preserved Ejection Fraction in the Young
Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors